Bio-Sourcing

Bio-Sourcing

Private
LiègeHealthcare & Life Scienceshttp://www.bio-sourcing.com

Last Round

VC Round

Sep 24, 2024

Total Funding Raised

$8.25M

Momentum Score

50 /100

Company Overview

Bio-Sourcing is a biotechnology company that develops a platform for producing biotherapeutics, such as monoclonal antibodies, in the milk of genetically engineered goats.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Smart Manufacturing

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

pharminganimal bioreactorsbiopharmaceutical manufacturingmonoclonal antibodiesmolecular farmingbiosimilar developmentbioproduction platformgene editingCRISPR-Cas9technology transferoral monoclonal antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bio-Sourcing Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bio-Sourcing Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 24, 2024
AcceleratorSep 24, 2024
GrantMay 28, 2024
Series ANov 7, 2014

Key People

Founding team and executive leadership

Bertrand Mérot

CEO

Executive Team

Maxime Wallerand

CFO

Executive Team

Brigitte Genard

COO

Executive Team

Bio-Sourcing Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Grew 20% QoQ, from 25 to 30 employees.

  • Mar 20, 2026

    Partnering with The Tiny Cargo Company on new antibody therapies.

Bio-Sourcing Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bio-Sourcing Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bio-Sourcing's valuation, stock price, and market status.

Firmographic Details

HeadquartersLiège
Employee Range30
Year Founded2014
Last FundingSep 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.